Search

everythinglearnresearchcommunity

for

Search:↓

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Scalp psoriasis features reversible hair loss and specific immune activation, with no significant hair follicle damage.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

JAK inhibitors show promise for treating various skin diseases.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

Keratin 17 is modified by RSK1 in response to growth and stress, affecting skin growth and stress response.

New therapies are being developed that target integrin pathways to treat various diseases.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Hidradenitis suppurativa is a skin disease caused by the breakdown of the skin's natural immune barriers, especially around hair follicles.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Skin cell-derived vesicles can help heal skin injuries effectively.

CBG may help with various medical conditions but needs more human research to confirm safety and effectiveness.

Transplant success has improved with better immunosuppressive drugs and donor matching.

The congress concluded that misuse of antifungal drugs in South Asia has led to widespread treatment failure, and new approaches and regional cooperation are needed.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Topical immunotherapy can treat alopecia areata, but its effectiveness varies and the exact mechanism is unclear.

Adenosine receptors could be promising targets for treating inflammatory skin diseases like psoriasis.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Mesenchymal Stem Cell therapy shows promise for treating hair loss in Alopecia Areata.